Search results
Results from the WOW.Com Content Network
MannKind Corp (NASDAQ: MNKD) is trading significantly lower Monday morning after the company announced the FDA issued a complete response to United Therapeutics regarding the New Drug Application ...
MannKind (MNKD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MannKind (MNKD) delivered earnings and revenue surprises of -25.00% and 31.12%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
For premium support please call: 800-290-4726 more ways to reach us
Founded in February 1991, the company's present form is a result of a 2003 merger of three companies owned by Alfred E. Mann: Pharmaceutical Discovery Corporation (PDC), the cancer vaccine developer CTL ImmunoTherapies, Inc., and its sister company Allecure Corp, which was developing an allergy vaccine technology.
Stocktwits is a social media platform designed for sharing ideas between investors, traders, and entrepreneurs. [1] Founded in 2008 by Howard Lindzon and Soren McBeth, it introduced the use of the cashtag, a way to group discussions around a stock symbol preceded by a dollar sign. [2]
For premium support please call: 800-290-4726 more ways to reach us
Stock indexes closed mostly lower Tuesday as the market delivered a downbeat finish on the final day of another milestone-shattering year on Wall Street. The Dow Jones Industrial Average slipped 0 ...